Mammography Global Market Report 2024

The mammography market has grown rapidly in recent years. It will grow from $2.36 billion in 2023 to $2.61 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The expansion witnessed in the historical period can be ascribed to the escalating incidence of breast cancer, heightened awareness, the implementation of screening programs, government initiatives and funding, advocacy and support groups, as well as improved reimbursement policies.

The mammography market is expected to see strong growth in the next few years. It will grow to $3.77 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The anticipated growth in the forecast period is linked to personalized medicine approaches, the expansion of breast cancer screening programs, growing collaboration in research, the adoption of telemedicine and remote screening, and a heightened focus on patient-centric care. Key trends expected in the forecast period encompass the dominance of digital mammography, the ascent of 3D mammography (tomosynthesis), the integration of artificial intelligence, a growing emphasis on personalized screening, the extension of applications beyond cancer screening, and advancements in breast imaging technologies.

The growth of the mammography market is anticipated to be propelled by the increasing incidence of breast cancer. Breast cancer, characterized by the uncontrolled proliferation of cells in the breast, is on the rise globally. Mammography, being a highly influential and widely utilized screening tool, plays a crucial role in the early detection and diagnosis of breast cancer. For instance, in 2023, it is projected that Breastcancer.org, a US-based nonprofit organization, estimates approximately 297,790 new cases of invasive breast cancer and 55,720 new cases of DCIS in U.S. women. The prevalence of breast cancer is evident, as in January 2023, the American Cancer Society reported 287,850 new instances of invasive breast cancer and 51,400 new cases of non-invasive (in situ) breast cancer in the United States for the year 2022. Consequently, the increasing incidence of breast cancer is a driving force behind the growth of the mammography market.

The growth of the mammography market is further fueled by the rising demand for early-stage diagnosis among patients. Early-stage diagnosis involves identifying and detecting diseases at their initial phases, often before noticeable symptoms manifest or the disease progresses. Mammography is integral to early-stage diagnosis due to its capability to detect breast abnormalities, such as tumors or calcifications, at the initial stages. This facilitates timely intervention, leading to improved treatment outcomes by enabling early intervention and reducing the risk of advanced breast cancer development. For instance, in October 2022, the National Health Service (NHS) England reported that more than 100,000 patients received a cancer diagnosis during stages one or two in the past year (2021-2022), representing the largest proportion ever diagnosed at more treatable stages. Hence, the increasing demand for early-stage diagnosis is a significant driver of the mammography market.

A key trend gaining traction in the mammography market is technological advancement. Leading players in the market are focused on developing cutting-edge technology to enhance their market share. For example, in August 2021, FUJIFILM Medical Systems U.S.A. Inc. collaborated with ScreenPoint Medical BV to launch Transpara, a breast imaging software powered by Fusion AI technology. This software employs artificial intelligence (AI) and deep learning algorithms to analyze mammography images, providing clinical decision support to radiologists. It aims to assist radiologists in identifying and diagnosing breast cancer at an early stage with higher accuracy and efficiency. The Transpara software offers AI-based breast cancer risk assessment, highlighting suspicious areas for further investigation. This technological innovation by major companies aligns with the goal of meeting evolving diagnostic demands and enhancing patient care in the mammography market.

Companies operating in the mammography market are actively pursuing product innovation, particularly in mammography systems, to meet changing diagnostic needs and elevate patient care standards. The Harmony version of the Amulet Innovality mammography system, introduced by Fujifilm Europe GmbH in April 2021, integrates improved diagnostics, aesthetic design, and advanced technologies. This innovation enhances reading efficiency by displaying comprehensive details in one image for a more patient-friendly environment.

In January 2021, Solis Mammography, a US-based company specializing in mammography and imaging services, acquired Progressive Radiology to expand its outpatient imaging geographic footprint in the DMV region. Through this acquisition, Solis Mammography strengthened its position in providing outpatient diagnostic imaging services, including mammography.

Major companies operating in the mammography market report are Hologic Inc., Fujifilm Corporation, Siemens Healthcare AG, Canon Medical Systems Corporation, GE Healthcare Company, Metaltronica S.p.A, Koninklijke Philips N.V., Gamma Medica Inc., Konica Minolta Inc., Carestream Health, PLANMED OY, Villa Sistemi Medicali Spa., Toshiba Medical Systems Corporation, Allengers Medical Systems Ltd., Analogic Corporation, IMS Srl, BMI Biomedical International s.r.l., General Medical Merate S.p.A., Genoray Co. Ltd., Agfa-Gevaert N.V., Delphinus Medical Technologies Inc., Micrima Limited, CMR Naviscan Corporation, Dilon Technologies Inc., Koning Corporation, Medi-Future Co. Ltd., PerkinElmer Inc., QView Medical Inc., Radmirtech Co. Ltd., SOREDEX, Trivitron Healthcare Pvt. Ltd., Ziehm Imaging GmbH, Zonare Medical Systems Inc.

North America was the largest region in the mammography market in 2023. The regions covered in the mammography market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mammography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Film screen systems, digital systems, analog systems, biopsy systems, 3D systems, and various others constitute the primary types of mammography products. Film screen mammography, a technique within this array, captures images of breast tissue on X-ray film and archives them. This method entails compressing the breast between two plates, subjecting it to X-rays, and developing the resultant image on specialized film.

The mammography market research report provides mammography market statistics, including mammography industry global market size, regional shares, competitors with a mammography market share, detailed mammography market segments, market trends and opportunities, and any further data you may need to thrive in the mammography industry. This mammography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mammography market includes revenues earned by entities by screening mammography, diagnostic mammography, digital mammography, and breast ultrasound. The market value includes the value of related goods sold by the service provider or included within the service offering. The mammography market also includes sales of mammography machines, compression paddles and radiographic films. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.